Navigation Links
Ebola Virus Thwarted After Exposure
Date:5/28/2010

Successful treatment in monkeys offers hope for humans, researchers say

FRIDAY, May 28 (HealthDay News) -- Researchers report that they've disrupted the ability of the Ebola virus to replicate in monkeys, potentially suggesting a treatment for humans who get infected with the lethal disease.

The study is the first to show that the treatment helps monkeys after exposure to the Ebola virus. Previous research showed that it worked when given as a vaccine before exposure.

The study, reported by Thomas W. Geisbert of Boston University School of Medicine and colleagues, focuses on bits of genetic material that target a protein that the virus needs to reproduce.

The notoriously deadly Ebola virus, found in Africa, causes massive bleeding and kills as many as 90 percent of the people it infects. Earlier this month, researchers reported that they'd created a vaccine that protects monkeys against three strains of the virus.

The findings were published May 27 in The Lancet.

More information

For more on research on Ebola fever and other acute viral diseases, see the National Institute of Allergy and Infectious Diseases.



-- Randy Dotinga



SOURCE: The Lancet, press release, May 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Experimental Vaccine Shields Monkeys Against Ebola
2. Scripps Research scientists reveal key structure from ebola virus
3. Anti-HIV Drugs May Help Prevent Spread of Virus
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Doctors Can Use Rotavirus Vaccine Again: FDA
8. Rotavirus Vaccine Helps Kids Avoid Severe Gastro Illness
9. Study finds rotavirus vaccine greatly reduces hospitalizations for acute gastroenteritis in children
10. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
11. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: